Feelobject Competitors

MindMaze is a global leader in digital neuro-therapeutics (DTx) solutions with a mission to accelerate the brain's ability to recover, learn and adapt. With over a decade of work at the intersection of neuroscience, bio-sensing, engineering, mixed reality and artificial intelligence, its healthcare division is addressing some of the most challenging problems in neurology, including stroke, Alzheimer disease and Parkinson disease, by creating the universal platform for brain health and recovery and unique digital therapeutic interventions. MindMaze's pioneering FDA cleared and CE marked neuro-digital therapeutics accelerate patients' recovery from many critical neurological conditions. Founded in 2012 by CEO Dr Tej Tadi, MindMaze is the first Swiss Unicorn with offices in Lausanne, Baltimore, London, Paris and Mumbai.

EMOTIV is a bioinformatics company advancing understanding of the human brain using electroencephalography (EEG). Our mission is to empower individuals to understand their own brain and accelerate brain research globally. Applications for the EMOTIV technology and interface span an incredible variety of industries - from gaming to interactive television, everyday computer interactions, hands-free control system, smart adaptive environments, art, accessibility design, market research, psychology, medicine, robotics, automotive, transport safety, defense and security. EMOTIV is a recognized pioneer and market leader in this field. Our products have won numerous international awards including the Red Dot Award, AutoVision Innovations Award, Australian International Design Awards, Australian Engineering Excellence Awards and Edison Awards. Our community of developers and researchers span over 120 countries.

Beyond Verbal is committed to identifying proprietary Vocal Biomarkers for personalized healthcare screening & monitoring based on your own voice. The Vocal Biomarker engine analyzes free speech using a proprietary speaker diarization tool to provide non-intrusive, continuous and scalable information on people health. Our early clinical findings demonstrated that by using BIG DATA, AI machine learning and deep learning techniques, we can predict and monitor chronic diseases and human emotions. Availability, high compliance and non-invasiveness of voice enable early screening, real time alerting and remote monitoring of various health conditions, such as cardiovascular (CAD and CHF), COPD, diabetes, sleep apnea, and others.